Karyopharm Therapeutics reported $1.69M in Trade Creditors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Amgen AMGN:US $ 1256M 147M
Avrobio Inc AVRO:US 28K 4.01M
Bristol Myers Squibb BMY:US $ 2882M 62M
Eli Lilly And LLY:US $ 1659.3M 226M
Enanta Pharmaceuticals ENTA:US $ 1.25M 4.74M
Epizyme EPZM:US $ 5M 2.91M
Karyopharm Therapeutics KPTI:US $ 1.69M 1.75M
Macrogenics MGNX:US $ 2.61M 1.12M
Mirati Therapeutics MRTX:US $ 24.27M 3.67M
Nektar Therapeutics NKTR:US $ 12.35M 0.27M
Novartis NOVN:VX 4.97B 114M
Novartis NVS:US $ 4969M 114M
Regeneron Pharmaceuticals REGN:US $ 534.2M 63.9M
Sangamo Biosciences SGMO:US 13.08M 1.93M
Takeda 4502:JP Y 424358M 91939M
Ultragenyx Pharmaceutical RARE:US $ 34.21M 10.53M
Xencor XNCR:US $ 15.75M 3.84M
YTE INCY:US $ 194.77M 42.22M